4th Dec 2020 13:26
Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
[This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)]
1 | Details of the person discharging managerial responsibilities/person closely associated
| |||||
a) | Name | Brendan McAtamney | ||||
| ||||||
| Reason for the notification
| |||||
a) | Position/status | PDMR - Chief Executive Officer - UDG Healthcare plc
| ||||
b) | Initial Notification Amendment | Initial Notification
| ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | UDG Healthcare plc
| ||||
b) | LEI |
549300IWG5ZPP6B8HH13 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code | Ordinary Shares of €0.05 each in UDG Healthcare plc
ISIN: IE0033024807 | ||||
b) | Nature of the transaction |
Grant of nominal cost options under the 2019 Performance Share Plan
| ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
| ||||
e) | Date of the transaction | 02/12/2020
| ||||
f) | Place of the transaction |
London Stock Exchange, Main Market
| ||||
g) | Additional Information | Period during which options can be exercised
4 DECEMBER 2025 to 4 DECEMBER 2027
| ||||
Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
[This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)]
1 | Details of the person discharging managerial responsibilities/person closely associated
| |||||
a) | Name | Nigel Clerkin | ||||
| ||||||
| Reason for the notification
| |||||
a) | Position/status | PDMR - Chief Financial Officer - UDG Healthcare plc
| ||||
b) | Initial Notification Amendment | Initial Notification
| ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | UDG Healthcare plc
| ||||
b) | LEI | 549300IWG5ZPP6B8HH13
| ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code | Ordinary Shares of €0.05 each in UDG Healthcare plc
ISIN: IE0033024807 | ||||
b) | Nature of the transaction |
Grant of nominal cost options under the 2019 Performance Share Plan
| ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
| ||||
e) | Date of the transaction |
02/12/2020
| ||||
f) | Place of the transaction |
London Stock Exchange, Main Market
| ||||
g) | Additional Information | Period during which options can be exercised
4 DECEMBER 2025 TO 4 DECEMBER 2027
| ||||
Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
[This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)]
1 | Details of the person discharging managerial responsibilities/person closely associated
| |||||
a) | Name | Ryan Quigley | ||||
| ||||||
| Reason for the notification
| |||||
a) | Position/status | PDMR - Chief Operating Officer - UDG Healthcare plc
| ||||
b) | Initial Notification Amendment | Initial Notification
| ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | UDG Healthcare plc
| ||||
b) | LEI | 549300IWG5ZPP6B8HH13
| ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code | Ordinary Shares of €0.05 each in UDG Healthcare plc
ISIN: IE0033024807 | ||||
b) | Nature of the transaction |
Grant of nominal cost options under the 2019 Performance Share Plan
| ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
| ||||
e) | Date of the transaction |
02/12/2020
| ||||
f) | Place of the transaction |
London Stock Exchange, Main Market
| ||||
g) | Additional Information | Period during which options can be exercised
4 DECEMBER 2023 TO 4 DECEMBER 2027
| ||||
Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
[This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)]
1 | Details of the person discharging managerial responsibilities/person closely associated
| |||||
a) | Name | Kevin Orfan | ||||
| ||||||
| Reason for the notification
| |||||
a) | Position/status | PDMR - President of Sharp Corporation
| ||||
b) | Initial Notification Amendment | Initial Notification
| ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | UDG Healthcare plc
| ||||
b) | LEI | 549300IWG5ZPP6B8HH13
| ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code | Ordinary Shares of €0.05 each in UDG Healthcare plc
ISIN: IE0033024807 | ||||
b) | Nature of the transaction |
Grant of nominal cost options under the 2019 Performance Share Plan
| ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
| ||||
e) | Date of the transaction | 02/12/2020
| ||||
f) | Place of the transaction | London Stock Exchange, Main Market
| ||||
g) | Additional Information | Period during which options can be exercised
4 JANUARY 2024 TO 4 DECEMBER 2027
| ||||
Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
[This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)]
1 | Details of the person discharging managerial responsibilities/person closely associated
| |||||
a) | Name | Amar Urhekar | ||||
| ||||||
| Reason for the notification
| |||||
a) | Position/status | PDMR - President of Ashfield Communications
| ||||
b) | Initial Notification Amendment | Initial Notification
| ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | UDG Healthcare plc
| ||||
b) | LEI | 549300IWG5ZPP6B8HH13
| ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code | Ordinary Shares of €0.05 each in UDG Healthcare plc
ISIN: IE0033024807 | ||||
b) | Nature of the transaction | Grant of nominal cost options under the 2019 Performance Share Plan
| ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
| ||||
e) | Date of the transaction | 02/12/2020
| ||||
f) | Place of the transaction | London Stock Exchange, Main Market
| ||||
g) | Additional Information | Period during which options can be exercised
4 JANUARY 2024 TO 4 DECEMBER 2027
| ||||
Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
[This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)]
1 | Details of the person discharging managerial responsibilities/person closely associated
| |||||
a) | Name | Greg Flynn | ||||
| ||||||
| Reason for the notification
| |||||
a) | Position/status | PDMR -President of Ashfield Commercial & Commercial
| ||||
b) | Initial Notification Amendment | Initial Notification
| ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | UDG Healthcare plc
| ||||
b) | LEI | 549300IWG5ZPP6B8HH13
| ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code | Ordinary Shares of €0.05 each in UDG Healthcare plc
ISIN: IE0033024807 | ||||
b) | Nature of the transaction |
Grant of nominal cost options under the 2019 Performance Share Plan
| ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
| ||||
e) | Date of the transaction |
02/12/2020
| ||||
f) | Place of the transaction |
London Stock Exchange, Main Market
| ||||
g) | Additional Information | Period during which options can be exercised
4 JANUARY 2024 to 4 DECEMBER 2027
| ||||
Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
[This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)]
1 | Details of the person discharging managerial responsibilities/person closely associated
| |||||
a) | Name | Colin Stanley | ||||
| ||||||
| Reason for the notification
| |||||
a) | Position/status | PDMR -President of Ashfield Advisory
| ||||
b) | Initial Notification Amendment | Initial Notification
| ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | UDG Healthcare plc
| ||||
b) | LEI | 549300IWG5ZPP6B8HH13
| ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code | Ordinary Shares of €0.05 each in UDG Healthcare plc
ISIN: IE0033024807 | ||||
b) | Nature of the transaction |
Grant of nominal cost options under the 2019 Performance Share Plan
| ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
| ||||
e) | Date of the transaction | 02/12/2020
| ||||
f) | Place of the transaction |
London Stock Exchange, Main Market
| ||||
g) | Additional Information | Period during which options can be exercised
4 DECEMBER 2023 TO 4 DECEMBER 2027
| ||||
Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
[This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)]
1 | Details of the person discharging managerial responsibilities/person closely associated
| |||||
a) | Name | Eimear Kenny | ||||
| ||||||
| Reason for the notification
| |||||
a) | Position/status | PDMR - Group Head of Human Resources - UDG Healthcare plc
| ||||
b) | Initial Notification Amendment | Initial Notification
| ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | UDG Healthcare plc
| ||||
b) | LEI | 549300IWG5ZPP6B8HH13
| ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code | Ordinary Shares of €0.05 each in UDG Healthcare plc
ISIN: IE0033024807 | ||||
b) | Nature of the transaction | Grant of nominal cost options under the 2019 Performance Share Plan
| ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
| ||||
e) | Date of the transaction |
02/12/2020
| ||||
f) | Place of the transaction |
London Stock Exchange, Main Market
| ||||
g) | Additional Information | Period during which options can be exercised
4 DECEMBER 2023 TO 4 DECEMBER 2027
| ||||
Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
[This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)]
1 | Details of the person discharging managerial responsibilities/person closely associated
| |||||
a) | Name | Liam Logue | ||||
| ||||||
| Reason for the notification
| |||||
a) | Position/status | PDMR - EVP, Corporate Development - UDG Healthcare plc
| ||||
b) | Initial Notification Amendment | Initial Notification
| ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | UDG Healthcare plc | ||||
b) | LEI |
549300IWG5ZPP6B8HH13 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code | Ordinary Shares of €0.05 each in UDG Healthcare plc
ISIN: IE0033024807 | ||||
b) | Nature of the transaction |
Grant of nominal cost options under the 2019 Performance Share Plan
| ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
| ||||
e) | Date of the transaction | 02/12/2020
| ||||
f) | Place of the transaction |
London Stock Exchange, Main Market
| ||||
g) | Additional Information | Period during which options can be exercised
4 JANUARY 2024 to 4 DECEMBER 2027
| ||||
Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
[This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)]
1 | Details of the person discharging managerial responsibilities/person closely associated
| |||||
a) | Name | Damien Moynagh | ||||
| ||||||
| Reason for the notification
| |||||
a) | Position/status | PDMR - General Counsel & Company Secretary - UDG Healthcare plc
| ||||
b) | Initial Notification Amendment | Initial Notification
| ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | UDG Healthcare plc | ||||
b) | LEI |
549300IWG5ZPP6B8HH13 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code | Ordinary Shares of €0.05 each in UDG Healthcare plc
ISIN: IE0033024807 | ||||
b) | Nature of the transaction |
Grant of nominal cost options under the 2019 Performance Share Plan
| ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
| ||||
e) | Date of the transaction |
02/12/2020
| ||||
f) | Place of the transaction |
London Stock Exchange, Main Market
| ||||
g) | Additional Information | Period during which options can be exercised
4 DECEMBER 2023 TO 4 DECEMBER 2027
| ||||
For further information, please contact:
Damien Moynagh
General Counsel & Company Secretary
Tel: +353-1-4689000
Related Shares:
UDG.L